Desk› Healthcare› Strides Pharma Science Ltd

Strides Pharma Science Ltd

BSE 532531 STAR INE939A01011

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 60 trading days

19 filings · 5 material · busiest 2026-07-21 and 2026-07-31

What it files

AGM / EGM4 Analyst / Investor Meet4 Press Release2 Results1 Investor Presentation1 Board Meeting1 Annual Report1 BRSR1

Filings

19 in the window

19 August 2026

Press Release

Press Release / Media Release

Strides receives USFDA Establishment Inspection Report (EIR) for flagship facility in Bengaluru

Company Update / Press Release / Media Release View filing →
18 August 2026

AGM / EGM

Shareholder Meeting / Postal Ballot-Scrutinizer's Report

Voting results along with Scrutinizers report for 35th AGM.

AGM/EGM / AGM View filing →
14 August 2026

AGM / EGM

Shareholder Meeting / Postal Ballot-Outcome of AGM

Proceedings of 35th Annual General Meeting of the Company

AGM/EGM / AGM View filing →
3 August 2026

Analyst / Investor Meet

Analyst / Investor Meet - Outcome

Transcript of Earnings Call pertaining to Unaudited Financial Results of the Company for the quarter ended June 30, 2026.

Company Update / Analyst / Investor Meet View filing →
31 July 2026

Results

Outcome Of Board Meeting Of The Company Held On July 31, 2026

Outcome of Board Meeting of the Company held on July 31, 2026

Result / Financial Results View filing →
31 July 2026

Press Release

Press Release / Media Release

Strides Delivers Steady Performance with Q1FY27; Revenue at Rs. 12,654m, Grew 13% YoY; Ex-US Markets Grew 17% YoY

Company Update / Press Release / Media Release View filing →
31 July 2026

Investor Presentation

Investor Presentation

Earnings Presentation for the quarter ended June 30, 2026

Company Update / Investor Presentation View filing →
31 July 2026

Analyst / Investor Meet

Analyst / Investor Meet - Outcome

Audio Recording of Earnings Call dated July 31, 2026, pertaining to unaudited financial results for Q1 FY27

Company Update / Analyst / Investor Meet View filing →
24 July 2026

Board Meeting

Board Meeting Intimation for Considering And Approving The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended June 30, 2026, Amongst Other Matters.

Strides Pharma Science Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2026 ,inter alia, to consider and approve the unaudited financial ....

Board Meeting / Board Meeting View filing →
24 July 2026

Analyst / Investor Meet

Analyst / Investor Meet - Intimation

Earnings Call to discuss the Unaudited Financial Results of the Company for the quarter ended June 30, 2026

Company Update / Analyst / Investor Meet View filing →
21 July 2026

AGM / EGM

Notice Of 35Th Annual General Meeting

35th Annual General Meeting is scheduled on Friday, August 14, 2026 at 12:15 HRS IST.

AGM/EGM / AGM View filing →
21 July 2026

Annual Report

Reg. 34 (1) Annual Report.

Annual Report for FY 2025-26

Others / Reg. 34 (1) Annual Report View filing →
21 July 2026

AGM / EGM

Notice Of 35Th Annual General Meeting

35th Annual General Meeting is scheduled to be held on Friday, August 14, 2026 at 12:15 hrs IST

AGM/EGM / AGM View filing →
21 July 2026

BRSR

Business Responsibility and Sustainability Reporting (BRSR)

Business Responsibility and Sustainability Report for FY 2026

Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →
20 July 2026

Record Date

Company Has Fixed The Record Date For Final Dividend For FY26 As Friday, July 31, 2026

Company has fixed the Record Date for Final Dividend for FY26 as Friday, July 31, 2026

Corp. Action / Record Date View filing →
8 July 2026

Compliance Certificate

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate in terms of regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018

Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
3 July 2026

Restructuring

Restructuring

Update on Completion of Transaction relating to Pivot Path.

Company Update / Restructuring View filing →
24 June 2026

Trading Window

Closure of Trading Window

Intimation regarding closure of Trading Window for the quarter ended June 30, 2026.

Insider Trading / SAST / Closure of Trading Window View filing →
8 June 2026

Analyst / Investor Meet

Analyst / Investor Meet - Intimation

Intimation of Schedule of Analyst/ Institutional Investors Meet

Company Update / Analyst / Investor Meet View filing →